Turkish Journal of Hematology (Jun 2009)

Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid

  • Jain Ankit,
  • Premalata CS,
  • Saini KV,
  • Bapsy PP,
  • Sajeevan KV,
  • Tejinder Singh,
  • Ullas Batra,
  • Babu Govind,
  • Lokanatha Dasappa,
  • Suresh Atilli,
  • Permeshwar R

Journal volume & issue
Vol. 26, no. 02
pp. 97 – 99

Abstract

Read online

Radioactive iodine (RAI) therapy plays an important role in the management of thyroid malignancies. Leukemia is a very rare complication of radioactive therapy. There are very few case reports with doses below 100 mCi causing leukemia. We report a case of papillary carcinoma of the thyroid treated with 80 mCi RAI who later developed acute myeloid leukemia. Thus, all patients with thyroid carcinoma treated with RAI should undergo periodic hematological examinations irrespective of RAI dose.

Keywords